Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer.

Heckman MG, Parker AS, Wu KJ, Hilton TW, Ko SJ, Pisansky TM, Schild SE, Khor LY, Hammond EH, Pollack A, Buskirk SJ.

Prostate. 2012 Dec 1;72(16):1757-66. doi: 10.1002/pros.22528. Epub 2012 Apr 18.

PMID:
22513981
[PubMed - indexed for MEDLINE]
2.

Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.

Simmons MN, Stephenson AJ, Klein EA.

Eur Urol. 2007 May;51(5):1175-84. Epub 2007 Jan 12. Review.

PMID:
17240528
[PubMed - indexed for MEDLINE]
3.

[Locally recurrent prostate cancer following radiation therapy: radical salvage prostatectomy].

Heidenreich A, Thüer D, Pfister D.

Urologe A. 2010 Jun;49(6):734-40. doi: 10.1007/s00120-009-2064-7. Review. German.

PMID:
20237908
[PubMed - indexed for MEDLINE]
4.

Radiotherapy for locally recurrent prostate cancer.

Kirkpatrick JP, Anscher MS.

Clin Adv Hematol Oncol. 2005 Dec;3(12):933-42. Review.

PMID:
16555435
[PubMed - indexed for MEDLINE]
5.

Tissue biomarkers for prostate cancer radiation therapy.

Tran PT, Hales RK, Zeng J, Aziz K, Salih T, Gajula RP, Chettiar S, Gandhi N, Wild AT, Kumar R, Herman JM, Song DY, DeWeese TL.

Curr Mol Med. 2012 Jul 1;12(6):772-87. Review.

PMID:
22292443
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk